Salivary biomarkers associated with myocardial necrosis: results from an alcohol septal ablation model.

[1]  Y. Nomura,et al.  Salivary biomarkers for predicting the progression of chronic periodontitis. , 2012, Archives of oral biology.

[2]  I. Mirzaii-Dizgah,et al.  Saliva-based creatine kinase MB measurement as a potential point-of-care testing for detection of myocardial infarction , 2012, Clinical Oral Investigations.

[3]  L. Jordan,et al.  Salivary endothelin-1 potential for detecting oral cancer in patients with oral lichen planus or oral cancer in remission. , 2011, Oral oncology.

[4]  J R Yates,et al.  Scientific Frontiers , 2011, Advances in dental research.

[5]  I. Mirzaii-Dizgah,et al.  Unstimulated whole saliva creatine phosphokinase in acute myocardial infarction. , 2011, Oral diseases.

[6]  F. Khan,et al.  Diagnostic Performance of High-Sensitivity Troponin T, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A Assays for Triage of Patients with Acute Myocardial Infarction , 2011, The Korean journal of laboratory medicine.

[7]  A. Vissink,et al.  Identification of autoantibody biomarkers for primary Sjögren's syndrome using protein microarrays , 2011, Proteomics.

[8]  Ashutosh Kumar Singh,et al.  Saliva/Pathogen Biomarker Signatures and Periodontal Disease Progression , 2011, Journal of dental research.

[9]  Timothy J Griffin,et al.  Hexapeptide libraries for enhanced protein PTM identification and relative abundance profiling in whole human saliva. , 2011, Journal of proteome research.

[10]  A. Gustafsson,et al.  Detection of suPAR in the Saliva of Healthy Young Adults: Comparison with Plasma Levels , 2011, Biomarker insights.

[11]  B. Karlan,et al.  Discovery and Preclinical Validation of Salivary Transcriptomic and Proteomic Biomarkers for the Non-Invasive Detection of Breast Cancer , 2010, PloS one.

[12]  A. Danese,et al.  Validation of a high-sensitivity assay for C-reactive protein in human saliva , 2010, Brain, Behavior, and Immunity.

[13]  Craig S. Miller,et al.  Current development of saliva/oral fluid-based diagnostics. , 2010, Texas dental journal.

[14]  John S. Hill,et al.  Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. , 2010, Journal of the American College of Cardiology.

[15]  S. Yusuf,et al.  Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. , 2010, European heart journal.

[16]  John T McDevitt,et al.  Current developments in salivary diagnostics. , 2010, Biomarkers in medicine.

[17]  D. Holtzman,et al.  Biomarkers will revolutionize the way we diagnose and treat Alzheimer's disease. , 2010, Biomarkers in medicine.

[18]  Eva Dubovsky,et al.  Correlation between serum cardiac markers and myocardial infarct size quantified by myocardial perfusion imaging in patients with hypertrophic cardiomyopathy after alcohol septal ablation. , 2010, The American journal of cardiology.

[19]  D. Opriș,et al.  Detection of Homocysteine and C-Reactive Protein in the Saliva of Healthy Adults: Comparison with Blood Levels , 2010, Biomarker insights.

[20]  D. Wong,et al.  Saliva: an emerging biofluid for early detection of diseases. , 2009, American journal of dentistry.

[21]  John Spertus,et al.  Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study. , 2009, Clinical chemistry.

[22]  S. Hazen,et al.  Myeloperoxidase, modified lipoproteins, and atherogenesis Published, JLR Papers in Press, December 16, 2008. , 2009, Journal of Lipid Research.

[23]  W. Dubinsky,et al.  Salivary biomarkers for the detection of malignant tumors that are remote from the oral cavity. , 2009, Clinics in laboratory medicine.

[24]  S. Nagueh,et al.  Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007. , 2008, JACC. Cardiovascular interventions.

[25]  Richard J. Kryscio,et al.  Bone remodeling biomarkers of periodontal disease in saliva. , 2008, Journal of periodontology.

[26]  Craig S. Miller,et al.  Lab‐on‐a‐Chip Methods for Point‐of‐Care Measurements of Salivary Biomarkers of Periodontitis , 2007, Annals of the New York Academy of Sciences.

[27]  E. Rossomando,et al.  Candidate salivary biomarkers associated with alveolar bone loss: cross-sectional and in vitro studies. , 2007, FEMS immunology and medical microbiology.

[28]  Craig S. Miller,et al.  Salivary biomarkers of existing periodontal disease: a cross-sectional study. , 2006, Journal of the American Dental Association.

[29]  K. Shimada,et al.  Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris. , 2006, The American journal of cardiology.

[30]  John T McDevitt,et al.  Toward the development of a lab-on-a-chip dual-function leukocyte and C-reactive protein analysis method for the assessment of inflammation and cardiac risk. , 2005, Clinical chemistry.

[31]  F. Ondrey,et al.  The feasibility of monitoring NF‐κB associated cytokines: TNF‐α, IL‐1α, IL‐6, and IL‐8 in whole saliva for the malignant transformation of oral lichen planus , 2005 .

[32]  S. Nagueh,et al.  A prospective follow‐up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy—The baylor experience (1996–2002) , 2005, Clinical cardiology.

[33]  John T McDevitt,et al.  Application of microchip assay system for the measurement of C-reactive protein in human saliva. , 2005, Lab on a chip.

[34]  Leong L Ng,et al.  Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction. , 2004, Journal of cardiac failure.

[35]  E. Antman,et al.  B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. , 2004, Journal of the American College of Cardiology.

[36]  I. Lamster,et al.  Beta-glucuronidase activity in saliva: relationship to clinical periodontal parameters. , 2003, Journal of periodontology.

[37]  W. Spencer,et al.  Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[38]  Nader Rifai,et al.  Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide , 2002, Circulation.

[39]  D. Karras,et al.  Serum markers in the emergency department diagnosis of acute myocardial infarction. , 2001, Emergency medicine clinics of North America.

[40]  C. Visser,et al.  CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction? , 2001, International immunopharmacology.

[41]  B. Davies,et al.  Salivary PAF in acute myocardial infarction and angina: changes during hospital treatment and relationship to cardiac enzymes. , 1994, Thrombosis research.

[42]  V. Musumeci,et al.  Tissue plasminogen activator in saliva of hypertensives treated with angiotensin converting enzyme inhibitors or calcium antagonists , 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[43]  M. Navazesh,et al.  Methods for Collecting Saliva , 1993, Annals of the New York Academy of Sciences.

[44]  D. Fine,et al.  Indicators of periodontal disease activity: an evaluation. , 1986, Journal of clinical periodontology.

[45]  I. Shannon,et al.  Saliva: composition and secretion. , 1974, Monographs in oral science.

[46]  F. Martin,et al.  Carcinoembryonic antigen in normal human saliva. , 1973, Journal of the National Cancer Institute.

[47]  David Akin,et al.  Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. , 2011, Oral oncology.

[48]  D. Atar,et al.  The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarction. , 2011, Clinical laboratory.

[49]  S. Habib,et al.  CRP levels are higher in patients with ST elevation than non-ST elevation acute coronary syndrome. , 2011, Arquivos brasileiros de cardiologia.

[50]  B. Norrving,et al.  Global atlas on cardiovascular disease prevention and control. , 2011 .

[51]  Syed Shahid Habib,et al.  Niveles de PCR son mayores en pacientes con síndrome coronario agudo y supradesnivel del segmento ST que en pacientes sin supradesnivel del segmento ST , 2011 .

[52]  John C. Gunsolley,et al.  Macrophage Inflammatory Protein‐1α: A Salivary Biomarker of Bone Loss in a Longitudinal Cohort Study of Children at Risk for Aggressive Periodontal Disease? , 2009 .

[53]  Craig S. Miller,et al.  NF-κB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma , 2005 .

[54]  A. Lusis,et al.  Modified Lipoproteins and Atherogenesis , 1992 .

[55]  O. Rennert.  Evaluation of laboratory tests proposed as aids for the diagnosis of cystic fibrosis. , 1973, Annals of clinical laboratory science.